Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content.

体外方法比较标的结合和CDC诱导治疗性抗体之间:应用在Biosimilarity分析
 
Click here for the English version

体外方法比较标的结合和CDC诱导治疗性抗体之间:应用在Biosimilarity分析

Article DOI: 10.3791/55542-v 07:25 min May 4th, 2017
May 4th, 2017

Chapters

Summary

Please note that all translations are automatically generated.

Click here for the English version.

该协议描述了利妥昔单抗的两个关键功能特征的体外比较:靶结合和补体依赖性细胞毒性(CDC)诱导。该方法用于参考利妥昔单抗和利妥昔单抗生物仿制药之间的对侧比较。这些测定可以在生物仿制发展过程中使用或作为其生产中的质量控制。

Tags

免疫学,第123,利妥昔单抗,生物仿制药,抗CD20,治疗性mAb,CDC,流式细胞术,Daudi细胞
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter